Anexelekto (AXL) Increases Resistance to EGFR-TKI and...

Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 2016 / 09 Vol. 24; Iss. 5

Anexelekto (AXL) Increases Resistance to EGFR-TKI and Activation of AKT and ERK1/2 in Non-Small Cell Lung Cancer Cells

Tian, Yaqiong, Zhang, Zengli, Miao, Liyun, Yang, Zhimin, Yang, Jie, Wang, Yinhua, Qian, Danwen, Cai, Hourong, Wang, Yongsheng
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
24
Language:
english
Journal:
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
DOI:
10.3727/096504016X14648701447814
Date:
September, 2016
File:
PDF, 632 KB
english, 2016
Conversion to is in progress
Conversion to is failed